SEP-225432

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSEP-225432
Drug Alias NameSEP-228432SEP-225432
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine reuptake inhibitorsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Dainippon
Inactive CompaniesSumitomo Pharma America Inc
Active IndicationsDepressive Disorder, MajorNeuralgia
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A